RxDoctor Payments Data

Kevin Liberty, DPM

Podiatrist · Burlington, WINPI 1982243432

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (46.2%), education and travel and lodging — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Mid-atlantic Surgical Systems, LLC at 30.2% of the total. Reporting peaked in 2022 at $4,484 and has fallen 99.0% since, to $44 in 2024. Among podiatrist clinicians in WI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$8,126in general payments, 2019–2025

Across 118 payments — averaging $68.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mid-atlantic Surgical Systems, LLC$2K
  • Orthofix Medical, Inc.$2K
  • Smith+Nephew$2K
  • Organogenesis Inc.$454
  • Misonix Inc$394
  • Flower Orthopedics Coporation$327
  • plus $552 from 7 others

What the payments were for

  • Travel & lodging$1,97224%
  • Food & beverage$3,75446%
  • Education$2,40030%

General payments by program year

20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,126 in reported general payments places this provider in the 90th percentile of 140 podiatrist providers in Wisconsin.

See all podiatrist providers in Wisconsin

Medicare billing

Part B allowed, 2024
$131,612
Medicare patients
527
Services billed
1,683

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip15$335
Clotrimazole12$314
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen26$160
Cephalexin11$97
Methylprednisolone12$82

Paid to pharmacies, not to this prescriber.

Other podiatrist in Burlington

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →